The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phosphorylation of Thr 495 Regulates Ca 2+ /Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity
Abstract
Abstract —The activity of the endothelial nitric oxide synthase (eNOS) can be regulated independently of an increase in Ca 2+ by the phosphorylation of Ser 1177 but results only in a low nitric oxide (NO) output. In the present study, we assessed whether the agonist-induced (Ca 2+ -dependent, high-output) activation of eNOS is associated with changes in the phosphorylation of Thr 495 in the calmodulin (CaM)-binding domain. eNOS Thr 495 was constitutively phosphorylated in porcine aortic endothelial cells and was rapidly dephosphorylated after bradykinin stimulation. In the same cells, bradykinin enhanced the phosphorylation of Ser 1177 , which was maximal after 5 minutes, and abolished by the CaM-dependent kinase II (CaMKII) inhibitor KN-93. Bradykinin also enhanced the association of CaMKII with eNOS. Phosphorylation of Thr 495 was attenuated by the protein kinase C (PKC) inhibitor Ro 31-8220 and after PKC downregulation using phorbol 12-myristate 13-acetate. The agonist-induced dephosphorylation of Thr 495 was completely Ca 2+ -dependent and inhibited by the PP1 inhibitor calyculin A. Little CaM was bound to eNOS immunoprecipitated from unstimulated cells, but the agonist-induced dephosphorylation of Thr 495 enhanced the association of CaM. Mutation of Thr 495 to alanine increased CaM binding to eNOS in the absence of cell stimulation, whereas the corresponding Asp 495 mutant bound almost no CaM. Accordingly, NO production by the Ala 495 mutant was more sensitive to Ca 2+ /CaM than the aspartate mutant. These results suggest that the dual phosphorylation of Ser 1177 and Thr 495 determines the activity of eNOS in agonist-stimulated endothelial cells. Moreover, the dephosphorylation of Thr 495 by PP1 precedes the phosphorylation of Ser 1177 by CaMKII. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In resting endothelial cells, Thr495 is generally phosphorylated”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“The phosphorylation has been attributed to protein kinase C (PKC) (297, 646), and the residue is dephosphorylated by protein phosphatase 1 (PP1)”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“Phosphorylation of Thr495 is a negative regulator of CaM binding to eNOS (297, 407, 646).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C. J., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 839
Self-citationNishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S., Uematsu, M., Nerem, R. M., Alexander, R. W., & Murphy, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116092 · Cited by 735
García‐Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
Phosphorylation of Endothelial Nitric Oxide Synthase in Response to Fluid Shear Stress
Corson, M. A., James, N. L., Latta, S. E., Nerem, R. M., Berk, B. C., & Harrison, D. G. (1996) · Circulation Research · doi:10.1161/01.res.79.5.984 · Cited by 521
Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
Busse, R., & Mülsch, A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80902-u · Cited by 511
Self-citationMolecular cloning and characterization of human endothelial nitric oxide synthase
Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M. A., Sundell, C. L., Wilcox, J. N., Lamas, S., & Michel, T. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80697-f · Cited by 489
Flagged first, then by citations
Research works printed but not linked: 5
- 10.1161/hyp.25.2.180 · DOI
- 10.1161/res.79.5.984 · DOI
- 10.1161/res.82.6.686 · DOI
- Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature. 1999;400:792]. Nature. 1999;399:597–601.
- 10.1161/res.78.5.750 · DOI
Cited by
Sorted by citations
Items 101–200 of 770
Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism
Nguyen, A., & Cai, H. “. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511011103 · Cited by 169
Kida, T., Tsubosaka, Y., Hori, M., Ozaki, H., & Murata, T. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301565 · Cited by 174
Oliveira‐Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2015) · Gene · doi:10.1016/j.gene.2015.09.061 · Cited by 175
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript phosphorylation at Thr495 decreases enzyme activity by impairing the binding of calciumactivated calmodulin (Fleming et al., 2001).”
BackgroundCho, D., Choi, Y. J., Jo, S. A., & Jo, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309451200 · Cited by 163
Vascular actions of insulin with implications for endothelial dysfunction
Potenza, M. A., Addabbo, F., & Montagnani, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2009 · Cited by 176
Li, P., Zhang, L., Zhang, M., Zhou, C., & Lin, N. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2491 · Cited by 159
Massion, P. B., & Balligand, J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.025973 · Cited by 159
“…cells, stimulation with histamine or bradykinin would first lead to dephosphorylation at this threonine residue, located in the critical calmodulin binding domain, to allow the binding of calmodulin, further stabilized by the subsequent phosphorylation on serine 1177 (Fleming et al. 2001).”
BackgroundMolecular Mechanisms Responsible for the Atheroprotective Effects of Laminar Shear Stress
Pan, S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2487 · Cited by 152
Novel nitric oxide signaling mechanisms regulate the erectile response
Burnett, A. L. “. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901209 · Cited by 156
Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders
Gielis, J. F., Lin, J. Y., Wingler, K., Schil, P. E. V., Schmidt, H. H. H. W., & Moens, A. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.018 · Cited by 158
“However, phosphorylation at Thr495 at the CaM binding domain prevents the increase in catalytic activity of eNOS by hindering the association of CaM with eNOS [22].”
BackgroundShao, Y., Cheng, Z. A., Li, X., Chernaya, V., Wang, H., & Yang, X. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0080-6 · Cited by 159
“This eNOS activation requires an elevation in intracellular free calcium concentration, formation of a complex with calmodulin and the removal of the inhibitory caveolin from the activated eNOS complex, although NO production is not affected by the components of PI3K-AKT pathway [46].”
BackgroundPotente, M., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305385200 · Cited by 155
Self-citationKuhr, F., Lowry, J., Zhang, Y., Brovkovych, V. M., & Skidgel, R. A. (2010) · Neuropeptides · doi:10.1016/j.npep.2009.12.004 · Cited by 154
“Additionally, adenosine monophosphate (AMP)-activated protein kinase (AMPK), protein kinase G (PKG), PKA and CaM-dependent kinase II (CaMKII) can activate eNOS by phosphorylating Ser (Chen, Lin, et al., 1999; Butt et al., 2000; Fleming et al., 2001).”
Murata, T., Sato, K., Hori, M., Ozaki, H., & Karaki, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205934200 · Cited by 153
Activation of Endothelial Nitric-oxide Synthase by the p38 MAPK in Response to Black Tea Polyphenols
Anter, E., Thomas, S. R., Schulz, E., Shapira, O. M., Vita, J. A., & Keaney, J. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405547200 · Cited by 142
VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells
Féliers, D., Chen, X., Akis, N., Choudhury, G. G., Madaio, M. P., & Kasinath, B. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00575.x · Cited by 140
“Other investigators have reported that ERK inhibitors do not affect nitric oxide generation or nitric oxide–mediated relaxation of isolated arterie”
BackgroundChing, L. ‐., Kou, Y. R., Shyue, S., Su, K., Wei, J., Cheng, L., Yu, Y., Pan, C.-C., & Lee, T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr104 · Cited by 141
Maniatis, N. A., Brovkovych, V. M., Allen, S. E., John, T. A., Shajahan‐Haq, A. N., Tiruppathì, C., Vogel, S. M., Skidgel, R. A., Malik, A. B., & Minshall, R. D. (2006) · Circulation Research · doi:10.1161/01.res.0000245187.08026.47 · Cited by 141
PKC Isozymes in Chronic Cardiac Disease: Possible Therapeutic Targets?
Churchill, E. N., Budas, G. R., Vallentin, A., Koyanagi, T., & Mochly‐Rosen, D. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154902 · Cited by 140
Fulton, D. J., Babbitt, R. W., Zoellner, S., Fontana, J. T., Acevedo, L. M., McCabe, T. J. D., Iwakiri, Y., & Sessa, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402155200 · Cited by 133
Abdelsalam, S. S., Korashy, H. M., Zeidan, A., & Agouni, A. (2019) · Biomolecules · doi:10.3390/biom9070286 · Cited by 135
Endothelial nitric oxide synthase in the microcirculation
Shu, X. H., Keller, T. C. S., Begandt, D., Butcher, J. T., Biwer, L. A., Keller, A., Columbus, L. M., & Isakson, B. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2021-0 · Cited by 128
Urbich, C., Reissner, A., Chavakis, E., Dernbach, E., Haendeler, J., Fleming, I., Zeiher, A. M., Kaszkin, M., & Dimmeler, S. (2002) · The FASEB Journal · doi:10.1096/fj.01-0637fje · Cited by 130
Self-citationCaMKII as a Therapeutic Target in Cardiovascular Disease
Gaido, O. E. R., Nkashama, L. J., Schole, K. L., Wang, Q., Umapathi, P., Mesubi, O. O., Konstantinidis, K., Luczak, E. D., & Anderson, M. E. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051421-111814 · Cited by 129
Fichtlscherer, S., Dimmeler, S., Breuer, S., Busse, R., Zeiher, A. M., & Fleming, I. (2003) · Circulation · doi:10.1161/01.cir.0000105763.51286.7f · Cited by 128
Self-citationExercise and Cardiovascular Health
Dimmeler, S., & Zeiher, A. M. (2003) · Circulation · doi:10.1161/01.cir.0000074244.82874.a0 · Cited by 128
Self-citationAngiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives
Iusuf, D., Henning, R. H., van Gilst, W. H., & Roks, A. J. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.090 · Cited by 127
Daiber, A., Kröller‐Schön, S., Oelze, M. W., Hahad, O., Li, H., Schulz, R., Steven, S., & Münzel, T. F. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101506 · Cited by 136
The CLDN5 gene at the blood-brain barrier in health and disease
Hashimoto, Y., Greene, C., Münnich, A., & Campbell, M. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00424-5 · Cited by 136
“Akt and calmodulin kinase phosphorylate S1177 of eNOS to activate it [126, 127] and PKA phosphorylates S633 of eNOS to up-regulate its enzymatic activity [128].”
BackgroundNitric oxide signalling in the regulation of cardiovascular and platelet function
Gkaliagkousi, Ε. (2010) · Frontiers in bioscience · doi:10.2741/3828 · Cited by 124
Osto, E., Doytcheva, P., Corteville, C., Bueter, M., Dörig, C., Stivala, S., Buhmann, H., Colin, S., Rohrer, L., Hasballa, R., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011791 · Cited by 128
Endothelium-derived Hyperpolarizing Factor
Bryan, R. M., You, J., Golding, E. M., & Marrelli, S. P. (2005) · Anesthesiology · doi:10.1097/00000542-200506000-00028 · Cited by 125
Time-course of endothelial adaptation following acute and regular exercise
Haram, P. M., Adams, V., Kemi, O. J., Brubakk, A. O., Hambrecht, R., Ellingsen, Ø., & Wisløff, U. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000198920.57685.76 · Cited by 123
Dhar, A., Dhar, I., Desai, K. M., & Wu, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01017.x · Cited by 122
“The reduced eNOS activity is likely due to reduced BK-stimulated serine-1177 [bovine eNOS serine-1179] phosphorylation of eNOS (Dimmeler et al., 1999; Fleming et al., 2001) caused by MG (30 mM) or glucose (25 mM) (Figure 6C).”
BackgroundSphingosine 1-phosphate and control of vascular tone
Dantas, A. P., Igarashi, J., & Michel, T. M. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01089.2002 · Cited by 120
“eNOS deactivation in the face of sustained Ser1179 phosphorylation may simply reflect the return of intracellular calcium concentration to baseline levels or may be consequent to phosphorylation of the enzyme at other residues (6, 15) or the intracellular translocation of the enzyme (27) leading to decreased extracell…”
BackgroundFleming, I., MOHAMED, A., GALLE, J., Turchanowa, L., Brandes, R. P., Fißlthaler, B., & Busse, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.003 · Cited by 120
“The phosphatase that dephosphorylates Thr(495) is thought to be PP1 [12,20], but although the PP1 inhibitor, calyculin A, was able to increase Thr(495) phosphorylation in ox-LDLtreated cells, we found no evidence to suggest that its activity or expression was increased by ox-LDL.”
InfluentialSelf-citationZhang, Q., McMillin, S. L., Tanner, J. M., Palionyte, M., Abel, E. D., & Symons, J. D. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172916 · Cited by 117
“Furthermore, ERK 1/2 has been reported to signal downstream to phosphorylate eNOS T495, a site responsible for decreasing eNOS activity (Chen et al. 1999; Bernier et al. 2000; Boo et al. 2001, 2002; Fleming et al. 2001; Rask-Madsen & King, 2005).”
BackgroundHarris, M. B., Blackstone, M. A., Sood, S. G., Li, C., Goolsby, J. M., Venema, V. J., Kemp, B. E., & Venema, R. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00214.2004 · Cited by 117
“In addition, we and others (8, 12) have reported that agonist-induced activation of eNOS is also due, in part, to rapid dephosphorylation of Thr-497 (bovine sequence).”
BackgroundSelf-citationeNOS Function and Dysfunction in the Penis
Musicki, B., & Burnett, A. L. “. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100205 · Cited by 118
Hristovska, A.-M., Rasmussen, L. E., Hansen, P., Nielsen, S. S., Nüsing, R. M., Narumiya, S., Vanhoutte, P. M., Skøtt, O., & Jensen, B. L. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088948 · Cited by 116
Park, J., Jin, Y. M., Hwang, S., Cho, D., Kang, D., & Jo, I. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.04.003 · Cited by 115
Birschmann, I., & Walter, U. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3579 · Cited by 115
Endothelial Function in Highly Endurance-Trained Men: Effects of Acute Exercise
Rognmo, Ø., Bjørnstad, T. H., Kahrs, C. R., Tjønna, A. E., Bye, A., Haram, P. M., Stølen, T., Slørdahl, S. A., & Wisløff, U. (2008) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31816354b1 · Cited by 112
“Interestingly, the shear stress-induced phosphorylation of eNOS is maintained (8), whereas agonist-mediated Ser 1177 phosphorylation, such as bradykinin, is only transient ( 10 ).”
BackgroundSoucy, K. G., Ryoo, S., Benjo, A., Lim, H. K., Gupta, G., Sohi, J. S., Elser, J., Aon, M. A., Nyhan, D., Shoukas, A. A., et al. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00138.2006 · Cited by 135
Clinical Significance of Endothelial Dysfunction in Essential Hypertension
Gkaliagkousi, Ε., Gavriilaki, E., Triantafyllou, Α., & Δούμα, Σ. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0596-3 · Cited by 112
Plaque-prone hemodynamics impair endothelial function in pig carotid arteries
Gambillara, V., Chambaz, C., Montorzi, G., Roy, S., Stergiopulos, N., & Silacci, P. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00486.2005 · Cited by 112
Li, H., Burkhardt, C., Heinrich, U., Brausch, I., Xia, N., & Förstermann, U. (2003) · Circulation · doi:10.1161/01.cir.0000066697.19571.af · Cited by 109
Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction
Yasar, ?., Bennet, A. M., Eliasson, E., Lundgren, S., Wiman, B., Fairé, U. D., & Rane, A. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00002 · Cited by 111
Regulation of Cellular Communication by Signaling Microdomains in the Blood Vessel Wall
Billaud, M., Lohman, A. W., Johnstone, S. R., Biwer, L. A., Mutchler, S. M., & Isakson, B. E. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007351 · Cited by 116
“In resting ECs, Thr495 is constitutively phosphorylated by 59AMP-activated protein kinase and PKC, antagonizing CaM binding in response to Ca-mobilizing agonists and functionally inhibiting NO synthesis by the enzyme (Fleming et al., 2001; Watts and Motley, 2009).”
BackgroundInfluentialScotland, R. S., Morales‐Ruiz, M., Chen, Y., Yu, J., Rudic, R. D., Fulton, D. J., Gratton, J., & Sessa, W. C. (2002) · Circulation Research · doi:10.1161/01.res.0000016506.04193.96 · Cited by 110
Src Kinase Activates Endothelial Nitric-oxide Synthase by Phosphorylating Tyr-83
Fulton, D. J., Church, J. E., Ruan, L., Li, C., Sood, S. G., Kemp, B. E., Jennings, I. G., & Venema, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504606200 · Cited by 112
Self-citationAndreozzi, F., Laratta, E., Procopio, M. C., Hribal, M. L., Sciacqua, A., Perticone, M., Miele, C., Perticone, F., & Sesti, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01340-06 · Cited by 116
“There is evidence that PP1 is involved in dephosphorylation of Thr495, and inhibition of PP1 by calyculin-A has been shown to enhance phosphorylation of Thr495 ( 12 ).”
BackgroundYang, B., & Rizzo, V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00758.2006 · Cited by 111
Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis
Barton, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0860-y · Cited by 109
The vital role for nitric oxide in intraocular pressure homeostasis
Reina‐Torres, E., Ieso, M. L. D., Pasquale, L. R., Madekurozwa, M., Sherwood, J. M., Overby, D. R., & Stamer, W. D. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100922 · Cited by 109
Kupatt, C., Dessy, C., Hinkel, R., Raake, P. W. J., Daneau, G., Bouzin, C., Boekstegers, P., & Féron, O. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000134300.87476.d1 · Cited by 108
Federici, M., Pandolfi, A., Filippis, E. A. D., Pellegrini, G., Menghini, R., Lauro, D., Cardellini, M., Romano, M., Sesti, G., Lauro, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000109498.77895.6f · Cited by 107
Bae, S. W., Kim, H. S., Nam, Y., Park, Y. S., Jo, S. A., & Jo, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01086-6 · Cited by 106
Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction
Tual‐Chalot, S., Guibert, C., Müller, B., Savineau, J., Andriantsitohaina, R., & Martínez, M. C. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1347oc · Cited by 105
Pandey, D., Gratton, J.-P., Rafikov, R., Black, S. M., & Fulton, D. J. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070193 · Cited by 95
Vascular Endothelium and Blood Flow
Busse, R., & Fleming, I. (2006) · Springer eBooks · doi:10.1007/3-540-36028-x_2 · Cited by 108
Self-citationFisslthaler, B., Loot, A. E., Mohamed, A., Busse, R., & Fleming, I. (2008) · Circulation Research · doi:10.1161/circresaha.108.172072 · Cited by 99
Self-citationXing, S.-S., Yang, X.-Y., Zheng, T., Li, W.-J., Wu, D., Chi, J.-Y., Bian, F., Bai, X.-L., Wu, G.-J., Zhang, Y.-Z., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.07.004 · Cited by 99
Nitric oxide delivery to cancer: Why and how?
Sonveaux, P., Jordan, B. F., Gallez, B., & Féron, O. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.018 · Cited by 103
Protein kinase C in enhanced vascular tone in diabetes mellitus
Kizub, I. V., Klymenko, K., & Soloviev, A. I. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.117 · Cited by 104
“As it has been shown in DM, PKC phosphorylates eNOS [117] on its inhibitory site Thr495 [123] and reduces eNOS phosphorylation on the activating Ser1177 site [124] blunting eNOS activity.”
BackgroundSuhr, F., Brenig, J., Müller, R., Behrens, H., Bloch, W., & Grau, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045982 · Cited by 98
“The phosphorylation of RBC-NOSSer, indicating increased enzyme activity [8,19], was significantly increased after AMRT, whereas total RBC-NOS and the phosphorylation of RBC-NOS at its Thr residue, indicating inhibition of NOS enzyme activity [36], were not affected by the applied exercise intervention.”
BackgroundNguyen, A., Chen, P., & Cai, H. “. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.061 · Cited by 98
PKCα Activates eNOS and Increases Arterial Blood Flow In Vivo
Partovian, C., Zhuang, Z., Moodie, K. L., Lin, M. I., Ouchi, N., Sessa, W. C., Walsh, K., & Simons, M. (2005) · Circulation Research · doi:10.1161/01.res.0000179775.04114.45 · Cited by 98
Stahmann, N., Woods, A., Spengler, K., Heslegrave, A., Bauer, R., Krause, S., Viollet, B., Carling, D., & Heller, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108688 · Cited by 100
CaM Kinase II-dependent pathophysiological signalling in endothelial cells
Cai, H. “., Liu, D., & Garcia, J. G. N. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm010 · Cited by 97
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension
Iwakiri, Y., Tsai, M.-H., McCabe, T. J. D., Gratton, J., Fulton, D. J., Groszmann, R. J., & Sessa, W. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00675.2001 · Cited by 97
Endothelial nitric oxide synthase: A potential therapeutic target for cerebrovascular diseases
Zhu, J., Song, W., Li, L., & Fan, X. (2016) · Molecular Brain · doi:10.1186/s13041-016-0211-9 · Cited by 96
Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells
Sugimoto, M., Nakayama, M., Goto, T. M., Amano, M., Komori, K., & Kaibuchi, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.030 · Cited by 96
Wang, H., Li, L., Jian-gang, J., Wang, Y., Lu, Z. Y., Bradbury, J. A., Lih, F. B., Wang, D. W., & Zeldin, D. C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052787 · Cited by 96
“In this regard, Fleming et al. (2001b) have recently shown that EETs activate the MAPK pathway in human endothelial and vascular smooth muscle cells.”
BackgroundInfluentialGonzalez, E., Kou, R., Lin, A. J., Golan, D. E., & Michel, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207299200 · Cited by 96
The Role of PPARγ in Cardiovascular Diseases
Kvandová, M., Majzúnová, M., & Dovinová, I. (2016) · Physiological Research · doi:10.33549/physiolres.933439 · Cited by 95
“…protein kinases, including PKA, PKB, PKC, AMPK, ERK and phosphatases such as protein phosphatase (PP)1 and S348 Kvandová et al. Vol. 65 PP2A in response to multiple stimuli via shear stress, growth factors, insulin, etc. (Fleming et al. 2001, Mount et al. 2007, Chen et al. 2009, Xiao et al. 2011).”
BackgroundOxidative Stress and Endothelial Nitric Oxide Bioactivity
Thomas, S. R., Chen, K., & Keaney, J. F. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603764816541 · Cited by 93
Functional role of NF-κB in expression of human endothelial nitric oxide synthase
Lee, K., Kim, J., Kwak, S.-N., Lee, K.-S., Lee, D.-K., Ha, K., Won, M., Jeoung, D., Lee, H., Kwon, Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.079 · Cited by 92
Schulz, C., Fichtlscherer, B., Kemp, B. E., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0228 · Cited by 91
“Washed human platelets were lysed and Triton X-100-soluble proteins were separated by SDS-PAGE as described (16).”
MethodSelf-citationRomero, M., Toral, M., Gómez‐Guzmán, M., Jiménez, R., Galindo, P., Sánchez, M., Olivares, M. M., Gálvez, J., & Duarte, J. (2015) · Food & Function · doi:10.1039/c5fo01101a · Cited by 91
Schneider, J., Kebir, D. E., Chéreau, C., Lanone, S., Huang, X., Roessingh, A. D. B., Mercier, J., DALL'AVA-SANTUCCI, J., & Dinh‐Xuan, A. T. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00932.2001 · Cited by 91
Lenasi, H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00505-4 · Cited by 91
Dixit, M., Loot, A. E., Mohamed, A., Fißlthaler, B., Boulanger, C. M., Ceacareanu, B., Hassid, A., Busse, R., & Fleming, I. (2005) · Circulation Research · doi:10.1161/01.res.0000195611.59811.ab · Cited by 90
Self-citationPharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88
Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase
Jeremy, J. Y., Jones, R. A., Koupparis, A. J., Hotston, M. R., Persad, R. A., Angelini, G. D., & Shukla, N. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901523 · Cited by 86
Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin
Venema, R. C. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00185-6 · Cited by 85
Intracellular Coupling via Limiting Calmodulin
Tran, Q., Black, D. J., & Persechini, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300165200 · Cited by 84
Thors, B., Halldórsson, H., & Þorgeirsson, G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.078 · Cited by 84
Emerging role of epoxyeicosatrienoic acids in coronary vascular function
Larsen, B. T., Gutterman, D. D., & Hatoum, O. A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01634.x · Cited by 83
Kida, M., Sugiyama, T., Yoshimoto, T., & Ogawa, Y. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.001 · Cited by 83
“In addition, CaM can activate CaM kinase II (CaMKII), which phosphorylates eNOS at its activating phosphoserine residue 1179 (Fleming et al., 2001).”
BackgroundMaternal Hypercholesterolemia in Pregnancy Associates With Umbilical Vein Endothelial Dysfunction
Leiva, A., de Medina, C. D., Salsoso, R., Sáez, T., Martín, S. S., Abarzúa, F., Farías, M., Guzmán‐Gutiérrez, E., Pardo, F., & Sobrevía, L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301987 · Cited by 83
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension
Gkaliagkousi, Ε., Δούμα, Σ., Zamboulis, C., & Ferro, A. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328330e89a · Cited by 81
Possible Pathomechanisms of Sudden Infant Death Syndrome
PRANDOTA, J. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000140648.30948.bd · Cited by 85
Barsacchi, R., Perrotta, C., Bulotta, S., Moncada, S., Borgese, N., & Clementi, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.886 · Cited by 82
Chong, J. H., & Ghosh, A. K. (2019) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2019.12 · Cited by 81
Coultrap, S. J., & Bayer, K. U. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.558254 · Cited by 83
Mechanism of Endothelial Nitric Oxide Synthase Phosphorylation and Activation by Thrombin
Motley, E. D., Eguchi, K., Patterson, M. M., Palmer, P. D., Suzuki, H., & Eguchi, S. (2007) · Hypertension · doi:10.1161/01.hyp.0000255954.80025.34 · Cited by 81
Payne, G. A., Bohlen, H. G., Dinçer, Ü. D., Borbouse, L., & Tune, J. D. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00116.2009 · Cited by 80
The Oxidative Stress Concept of Nitrate Tolerance and the Antioxidant Properties of Hydralazine
Daiber, A., Mülsch, A., Hink, U., Mollnau, H., Warnholtz, A., Oelze, M. W., & Münzel, T. F. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.030 · Cited by 84
Proteasome Inhibition Down-regulates Endothelial Nitric-oxide Synthase Phosphorylation and Function
Wei, Q., & Xia, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602105200 · Cited by 79
Metadata
- Authors
- Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation Research
- Published
- 2001-06-08
- Volume
- 88
- Issue
- 11
- Pages
- E68-75
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2135297555
- Cited by
- 770
- References
- 38
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 18 · 2017: 29 · 2016: 30 · 2015: 39 · 2014: 34 · 2013: 28 · 2012: 49
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft (SFB 553)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- endothelial nitric oxide synthase, calmodulin binding, CaMKII, PP1 phosphatase, calyculin A, bradykinin, protein kinase C, nitric oxide production, endothelial cells, dual phosphorylation, calmodulin-dependent kinase II, calmodulin
- MeSH terms
- Animals, Binding Sites, Bradykinin, Calcium, Calmodulin, Cells, Cultured, Coronary Vessels, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Phosphorylation, Precipitin Tests, Protein Kinase C, Proto-Oncogene Proteins, Swine, Threonine, Blotting, Western, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Nitric Oxide Synthase, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Nitric Oxide Synthase Type III, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review